News Focus
News Focus
icon url

was hotlinktuna

04/03/06 4:07 PM

#465727 RE: Zeev Hed #465711

Zeev, I see PETS closed 15.90 well off the LOD...I'd hoped to do some trading the last 20 minutes and got company that just left...had a good day overall but EDGR hurt me I see of my remaining holdings...tuna
icon url

madrose1

04/10/06 7:06 AM

#466678 RE: Zeev Hed #465711

MYOG Myogen announces positive top line results for pivotal Phase 3 trial of ambrisentan (35.82 )

Co announces positive top line results of the ARIES-1 trial, the second pivotal Phase 3 trial evaluating ambrisentan, an oral endothelin receptor antagonist, in pulmonary arterial hypertension. The trial met the primary efficacy endpoint of improved exercise capacity for both ambrisentan dose groups, with an excellent safety profile and no observed liver function abnormalities in the ambrisentan treatment groups. Co expects to submit the ambrisentan N.D.A. to the FDA in Q4.

MYOG reports positive Phase III results for Ambrisentan
Myogen, Inc. announced positive top line results of the ARIES-1 trial, the second pivotal Phase 3 trial evaluating ambrisentan, an oral endothelin receptor antagonist, in pulmonary arterial hypertension. The trial met the primary efficacy endpoint of improved exercise capacity for both ambrisentan dose groups, with an excellent safety profile and no observed liver function abnormalities in the ambrisentan treatment groups. On the basis of the results of ARIES-1 & -2, Myogen expects to submit the ambrisentan New Drug Application to the U.S. Food and Drug Administration in the fourth quarter of 2006. :



icon url

madrose1

04/10/06 9:20 AM

#466715 RE: Zeev Hed #465711

once again MYOG stubbornly holds $34 so far in the premrkt ...